Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3654 (miR-3654) is a small, non-coding RNA molecule classified as a microRNA, which regulates gene expression at the post-transcriptional level by binding to complementary sequences on target messenger RNAs (mRNAs), typically resulting in translational repression or mRNA degradation[2][3]. The expression of miR-3654 has been observed to be upregulated in prostate cancer cells compared to normal and certain androgen-insensitive cancer cell lines, suggesting an involvement in the progression of prostate cancer[1]. Like other microRNAs, miR-3654 may function in diverse biological processes such as cellular proliferation, differentiation, and apoptosis, often acting as a fine-tuner or rheostat for gene expression[2]. There is currently limited direct evidence on specific drugs or clinical biomarkers for miR-3654, and further studies are needed to elucidate its molecular targets and mechanisms in human disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3654 (miR-3654).